Polyethyleneimine-modified pectin beads for colon-specific drug delivery: In vitro and in vivo implications

Journal of Microencapsulation

Volumn 28, Issue 4, 2011, Pages 268-279

  Das, Surajit ^a,b   Chaudhury, Anumita ^a   Ng, Ka Yun ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF CHEMICAL AND ENGINEERING SCIENCES   (Singapore)

Author keywords

bead; calcium pectinate; colon specific; polyethyleneimine; resveratrol

Indexed keywords

CALCIUM PECTINATE BEAD; DRUG CARRIER; POLYETHYLENEIMINE; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COLON DISEASE; CROSS LINKING; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SUSPENSION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; COLON; COLONIC DISEASES; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; MALE; MICROSPHERES; PECTINS; POLYETHYLENEIMINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79955791393     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2011.559284     Document Type: Article

References (32)

1. Atyabi F, Majzoob S, Iman M, Salehi M, Dorkoosh F. In vitro evaluation and modification of pectinate gel beads containing trimethyl chitosan, as a multi-particulate system for delivery of water-soluble macromolecules to colon. Carbohydr Polym, 2005;61:39-51. (Pubitemid 40774011)
2. Basit AW. Advances in colonic drug delivery. Drugs, 2005;65:1991-2007. (Pubitemid 41324059)
3. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 2006;444:337-42. (Pubitemid 44764104)
4. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov, 2006;5:493-506. (Pubitemid 44136961)
5. Bourgeois S, Laham A, Besnard M, Andremont A, Fattal E. In vitro and in vivo evaluation of pectin beads for the colon delivery of beta-lactamases. J Drug Target, 2005;13:277-84. (Pubitemid 41283161)
6. Bourgeois S, Tsapis N, Honnas H, Andremont A, Shakweh M, Besnard M, Fattal E. Colonic delivery of beta-lactamases does not affect amoxicillin pharmacokinetics in rats. J Pharm Sci, 2008;97:1853-63.
7. Das S, Lin HS, Ho PC, Ng KY. The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharm Res, 2008; 25:2593-600.
8. Das S, Ng KY. Colon-specific delivery of resveratrol: Optimization of multiparticulate calcium-pectinate carrier. Int J Pharm, 2010a;385:20-8.
9. Das S, Ng KY. Resveratrol-loaded calcium-pectinate beads: Effects of formulation parameters on drug release and bead characteristics. J Pharm Sci, 2010b;99:840-60.
10. Fan LF, He W, Bai M, Du Q, Xiang B, Chang YZ, Cao DY. Biphasic drug release: Permeability and swelling of pectin/ethylcellulose films, and in vitro and in vivo correlation of film-coated pellets in dogs. Chem Pharm Bull, 2008;56:1118-25.
11. Friend DR. New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev, 2005;57:247-65. (Pubitemid 39536101)
12. Gescher AJ, Steward WP. Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: A conundrum. Cancer Epidemiol Biomarkers Prev, 2003;12:953-7. (Pubitemid 37310248)
13. Kaldas MI, Walle UK, Walle T. Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol, 2003;55:307-12. (Pubitemid 36410351)
14. Kaur K, Kim K. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery. Int J Pharm, 2009;366:140-8.
15. Krishnaiah YS, Satyanarayana V, Dinesh Kumar B, Karthikeyan RS, Bhaskar P. In vivo pharmacokinetics in human volunteers: Oral administered guar gum-based colon-targeted 5-fluorouracil tablets. Eur J Pharm Sci, 2003;19:355-62. (Pubitemid 36952397)
16. Liu L, Fishman ML, Kost J, Hicks KB. Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials, 2003;24:3333-43. (Pubitemid 36581891)
17. Maestrelli F, Cirri M, Corti G, Mennini N, Mura P. Development of entericcoated calcium pectinate microspheres intended for colonic drug delivery. Eur J Pharm Biopharm, 2008a;69:508-18.
18. Maestrelli F, Zerrouk N, Cirri M, Mennini N, Mura P. Microspheres for colonic delivery of ketoprofen-hydroxypropyl-beta-cyclodextrin complex. Eur J Pharm Sci, 2008b;34:1-11.
19. Maier-Salamon A, Hagenauer B, Wirth M, Gabor F, Szekeres T, Jager W. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Pharm Res, 2006;23:2107-15.
20. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linkedrat model. J Pharmacol Exp Ther, 2002;302:369-73. (Pubitemid 34680460)
21. Martin AR, Villegas I, La Casa C, De La Lastra CA. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol, 2004;67:1399-410. (Pubitemid 38315105)
22. Martin AR, Villegas I, Sanchez-Hidalgo M, De La Lastra CA. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol, 2006;147:873-85.
23. Munjeri O, Hodza P, Osim EE, Musabayane CT. An investigation into the suitability of amidated pectin hydrogel beads as a delivery matrix for chloroquine. J Pharm Sci, 1998;87:905-8. (Pubitemid 28381244)
24. Musabayane CT, Munjeri O, Bwititi P, Osim EE. Orally administered, insulin- loaded amidated pectin hydrogel beads sustain plasma concentrations of insulin in streptozotocin-diabetic rats. J Endocrinol, 2000;164:1-6. (Pubitemid 30044323)
25. Rodriguez M, Vila-Jato JL, Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release, 1998;55:67-77. (Pubitemid 28477565)
26. Schneider Y, Duranton B, Gosse F, Schleiffer R, Seiler N, Raul F. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer, 2001;39:102-7. (Pubitemid 32880955)
27. Sriamornsak P. Effect of calcium concentration, hardening agent and drying condition on release characteristics of oral proteins from calcium pectinate gel beads. Eur J Pharm Sci, 1999;8:221-7. (Pubitemid 29324650)
28. Tessitore L, Davit A, Sarotto I, Caderni G. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis, 2000;21:1619-22. (Pubitemid 30608219)
29. Walle T, Hsieh F, Delegge MH, Oatis Jr JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos, 2004;32:1377-82. (Pubitemid 39564557)
30. Wong TW, Nurjaya S. Drug release property of chitosan-pectinate beads and its changes under the influence of microwave. Eur J Pharm Biopharm, 2008;69:176-88. (Pubitemid 351467159)
31. Wu B, Deng D, Lu Y, Wu W. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs. Eur J Pharm Biopharm, 2008; 69:294-302. (Pubitemid 351467163)
32. Zhao XL, Li KX, Zhao XF, Pang DH, Chen DW. Study on colon-specific 5-Fu pH-enzyme Di-dependent chitosan microspheres. Chem Pharm Bull, 2008;56:963-8.